Dhanvantri Jeevan Rekha Ltd.
BSE: 531043 | Sector: Health care |
NSE: N.A. | ISIN Code: INE239F01015 |
BSE 12:19 | 08 Aug | 13.50 |
-0.15 (-1.10%) |
OPEN
13.65 |
HIGH
13.65 |
LOW
13.50 |
NSE 05:30 | 01 Jan | Dhanvantri Jeevan Rekha Ltd |
OPEN | 13.65 |
PREVIOUS CLOSE | 13.65 |
VOLUME | 1220 |
52-Week high | 21.87 |
52-Week low | 7.50 |
P/E | 16.88 |
Mkt Cap.(Rs cr) | 6 |
Buy Price | 13.50 |
Buy Qty | 2.00 |
Sell Price | 14.00 |
Sell Qty | 334.00 |
Dhanvantri Jeevan Rekha Ltd. (DHANVANTRIJEEV) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Dr Reddy's Labs | 4218.05 | 62.05 | 1.49 | 14405.20 |
Cipla | 1027.70 | -6.55 | -0.63 | 13091.79 |
Sun Pharma.Inds. | 913.35 | -1.85 | -0.20 | 12803.21 |
Lupin | 664.90 | -3.05 | -0.46 | 11771.67 |
Aurobindo Pharma | 570.50 | 1.95 | 0.34 | 11287.14 |
Divi's Lab. | 3909.40 | -1.65 | -0.04 | 8879.82 |
Alkem Lab | 2968.70 | -142.95 | -4.59 | 8829.81 |
Zydus Lifesci. | 363.40 | 6.20 | 1.74 | 7981.90 |
Glenmark Pharma. | 372.80 | -5.45 | -1.44 | 7567.93 |
Torrent Pharma. | 1556.10 | 0.40 | 0.03 | 6742.32 |
Apollo Hospitals | 4436.70 | 63.50 | 1.45 | 6098.30 |
Ipca Labs. | 1007.05 | -8.10 | -0.80 | 5399.36 |
Alembic Pharma | 664.80 | -7.85 | -1.17 | 5051.44 |
Abbott India | 20412.10 | 16.55 | 0.08 | 4919.27 |
Laurus Labs | 550.70 | 5.45 | 1.00 | 4707.04 |
Gland Pharma | 2321.05 | 60.15 | 2.66 | 3462.88 |
Granules India | 313.50 | 2.55 | 0.82 | 3238.44 |
Glaxosmi. Pharma | 1424.45 | 16.60 | 1.18 | 3217.51 |
Ajanta Pharma | 1275.35 | -3.40 | -0.27 | 3140.64 |
Sanofi India | 6551.95 | 13.15 | 0.20 | 2956.60 |
Quick Links for Dhanvantri Jeevan Rekha:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices